Fosfomycin trometamol in patients with renal insufficiency and in the elderly

International Arabic Journal of Antimicrobial Agents

Volumn 2, Issue 1, 2012, Pages

  Naber, Kurt G ^a   Thomas, Petra ^b   Fünfstück, Reinhard ^c  

^a PIERRE FABRE PHARMA GmbH ^*  (Germany)

^b Centre d'Immunologie Pierre Fabre   (France)

^c Sophien und Hufeland Klinikum Weimar   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886915344     PISSN: None     EISSN: 21749094     Source Type: Journal    
DOI: 10.3823/707     Document Type: Article

References (39)

1. Grabe M, Bjerklund Johansen TE, Botto H, Wullt B, Cek M, Naber KG, Pickard RS, Tenke P, Wagenlehner FME. 2011. Guidelines on urological infections. European Association of Urology, Arnhem, The Netherlands, ISBN/EAN: 978-90-79754-96-0.
2. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. 2011. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. CID: 52: e103-e120.
3. Wagenlehner FME, Schmiemann G, Hoyme U, Fünfstück R, Hummers-Pradier E, Kaase M, Kniehl E, Selbach I, Sester U, Vahlensiek W, Watermann D, Naber KG. Epidmiology, diagnostics, therapy and management of uncomplicated bacterial community acquired urinary tract infections in adults (short version 17 June 2010). Chemother J. 2011, 20:158-168.
4. Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI, Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65: 1862-1877.
5. Lecomte F, Allaert FA,. Single-dose treatment of cystitis with fosfomycin trometamol: analysis of 15 comparative trials on 2.048 patients. Gior. It. Ost. Gin. 1997, 7-8
6. Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents. 1998, 10:39-47.
7. Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS. Risk factors for extended-spectrum b-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010,16: 147-151.
8. Lee S-J, Lee DS, Choe HS, Shim BS, Kim CS, Kim ME, Cho Y-H. 2011. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother. 2011, 17:440-446.
9. Della Bella D, Ferrari V, 1988. Monuril: historical background. In Neu, Williams (eds), New Trends in Urinary Tract Infections. Int. Symp., Rome 1987, pp 116-120 (Karger, Basel)
10. Kahan FM, Kahan JS, Cassidy PJ, Kropp H, 1974. The mechanism of action of fosfomycin (phosphonomycin). Ann NY Acad Sci. 1974, 235:364-385.
11. Bergan T, 1990. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Infection 18, Suppl 2:S65-S69
12. Wiedemann B, Gross M. Antibacterial activity of fosfomycin trometamol in the urine after simulation of oral doses in a pharmacokinetic in vitro model. Eur Urol 1987, 13 Suppl 1:76-79.
13. Borsa F, Leroy A, Fillastre J-P, Godin M, Moulin B. Antimicr Agents Chemother 1988, 32:938-941.
14. Scaglione F, Cicchetti F, Demartini G, Arcidiacono M. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt. Int J Clin Pharm Res.1994, 14:107-109.
15. Fillastre J P, Leroy A, Josse S, Moulin B. Étude pharmacocinétique du trométamol-fosfomycine chez les malades insuffsants rénaux. Pathologie Biologie.1988, 36:728-730.
16. Jangknecht R, Hooymans PM, Fabius GTJ, Nohlmans-Paulssen MKE, Machielsen C, Boogaard-Van Den Born J, Rang J, Smits CAM, Willems-Thissen ME, Krommenhoek A. Pharmacy World & Science. 1994, 16:149-153.
17. Clinical and Laboratory Standards Institute, 2009. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S19 Wayne, PA, USA: CLSI.
18. European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2010. Available at http://www.eucast.org
19. Schito GC, Gualco L, Naber KG, Botto H, Palou J, Mazzei T, Marchese A, 2010. Do different susceptibility breakpoints affect the selection of antimicrobials for treatment o uncomplicated cystitis? Journal of Chemotherapy 22: 345-355
20. Stein GE, 1998. Single-dose treatment of acute cystitis with fosfomycin tromethamine. Ann Pharmacotherapy 32:215-219.
21. Naber KG, Wullt B, Wagenlehner FME, 2011. Antibiotic treatment of uncomplicated urinary tract infections in premenopausal women. Int J Antimicr Agents Suppl 38S: 21-35.
22. Rudenko N, Dorofeyev A, 2005. Prevention of urinary tract infections by long-term administration of fosfomycin trometamol. Arzneim.-Forsch,/Drug Res. 55:420-427.
23. MacGowan AP, Bailey RA, Egner W, Picken DM, Reeves DS, 1990. An open study of the effcacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study). Infection 18, Suppl 2: S107-S108.
24. Bayrak O, 2007. Is single dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy. Int Urogynecol J Pelvic Floor Dysfunct 18:525-529.
25. Reeves DS, 1992. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection 20 Suppl 4:S313-S316
26. Periti P, Novelli A, Reali EF, Lamanna S, Fontana P, 1987. Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. Eur Urol 13 Suppl 1:122-131.
27. Baert L, Billiet I, Vandepitte J, 1990. Prophylactic chemotherapy with fosfomycin trometamol versus placebo during thransurethral prostatic resection. Infection 18, Suppl 2: S103-S106.
28. Di Silverio F, Ferrone G, Carati L, 1990. Prophylactic chemotherapy with fosfomycin trometamol during transurethral and urological manouvres. Results of a multicentre study. Infection 18, Suppl 2: S98-S102.
29. Pulluku H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir S, Ulusoy S, 2007. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicr Agents 29:62-65.
30. Senol S, Tasbakan M, pullukcu H, Sipahi OR, Sipahi H, Yamazhan T, Arda B, Ulusoy S, 2010. Carbapenem versus fosfomycin tromethamol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated urinary tract infection. J Chemother 22:355-357.
31. Shrestha MK, Amuh D, Goldman MP, Riebel WJ, Tomford JW, 2000. Treatment of a complicated vancomycon-resistant enterococcal urinary tract infection with fosfomycin. Infectious Diseases in Clinical Practice 9:368-371
32. Ruxer J, Mozdzan M, Siejka A, Loba J, Markuszewski L, 2006. Fosfomycin and nitrofurantoin in the treatment of recurrent urinary tract infections in type 2 diabetic women. A preliminary report. Diabetologia Doswiadczalna/Kliniczna 6(5):277-282.
33. Brasch H, Theis E, Iven H, 1982. Pharmacokinetics of TRIS (hydroxymethyl-)aminomethane in healthy subjects and in patients with metabolic acidosis. Eur J Pharmacol. 22: 257-264
34. Fünfstück R, Naber KG, Bishop MC, 2010. Urinary tract infections in patients with renal insuffciency and dialysis. Epidemiology, pathogenesis, clinical symptoms, diagnostics and treatment. pp 426-437. In: Naber KG, Schaeffer AJ, Heyns CF, Matsumoto T, Shoskes DA, Bjerklund Johansen TE (eds): Urogenital Infections. European Association of Urology -International Consultation on Urological Diseases, 1st edition 2010, Arnhem, The Netherlands, ISBN:978-90-79754-41-0.
35. Hartmann B, Czock D, Keller F, 2010. Arzneimitteltherapie bei Patienten mit chronischem Nierenversagen. Deutsches Ärzteblatt 107: 647-656.
36. Grasso S, Meinard G, Carneri I, Tamassia V, 1978. New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity. Antimicrob. Agents Chemother. 13:570-576
37. Gior. It. Ost. Gin. 1997, 7-8
38. Rudenko N, Dorofeyev A, 2006. Treatment of acute non complicated cystitis in elderly women. Giornale Italiano di Microbiologia Medica Odontoiatrica e Clinica 10:3-10.
39. Rudenko N, Dorofeyev A, 2005. Prevention of urinary tract infections by long-term administration of fosfomycin trometamol. Arzneim.-Forsch,/Drug Res. 55:420-427.